The Cancer Institute of New Jersey — New Brunswick, New Jersey

The Cancer Institute of New Jersey is a clinical research site located in New Brunswick, New Jersey, United States 08903.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

The Cancer Institute of New Jersey has participated in 30 clinical trials.

Therapeutic areas: Prostate Cancer, Ovarian Neoplasms, Ovarian Cancer.

Sponsors: Bavarian Nordic, KangLaiTe USA, Telik.

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Cancer Institute of New Jersey?

The Cancer Institute of New Jersey has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Cancer Institute of New Jersey conducted?

The Cancer Institute of New Jersey has 30 clinical trials on record. Their work covers Prostate Cancer, Ovarian Neoplasms, Ovarian Cancer.

Is The Cancer Institute of New Jersey accredited by Crixeo Health?

Yes — The Cancer Institute of New Jersey holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about The Cancer Institute of New Jersey?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.